(Q43933317)

28 November 2017

title

Probiotic research: learn from the evidence (English)

1 reference

28 November 2017

0 references

Isolauri E

1

1 reference

28 November 2017

Rautava S

2

1 reference

28 November 2017

Kalliomäki M

3

1 reference

28 November 2017

Kirjavainen P

4

1 reference

28 November 2017

Salminen S

5

1 reference

28 November 2017

publication date

1 November 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

57

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

1076-7; author reply 1078

1 reference

Probiotics: a novel approach in the management of food allergy

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Serum IgE levels during the first 6 years of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Functional food science and gastrointestinal physiology and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Role of probiotics in food hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

Probiotics against allergy: data, doubts, and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

Fetal and neonatal IL-13 production during pregnancy and at birth and subsequent development of atopic symptoms

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

Oral bacteriotherapy for viral gastroenteritis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

Differences in Bifidobacterium flora composition in allergic and healthy infants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

Intestinal Bifidobacterium species induce varying cytokine production

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23804.X

7 January 2021

10.1034/J.1398-9995.2002.23804.X

Identifiers

DOI

1 reference

28 November 2017

1 reference